The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Editorial
Chronic total coronary occlusions and the Occluded Artery Trial. A critical appraisal.
EuroInterv.2008;4:23-27.
Gerald S. Werner1*, MD, FACC, FESC; Carlo Di Mario2, MD, FACC, FRCP, FESC; Alfredo R. Galassi3, MD, FACC, FESC; Anthony Gershlick4, MD, FRCP, FESC; Bernhard Reimers5, MD, FESC; George Sianos6, MD, PhD, FESC; Horst Sievert7, MD, PhD, FESC; Thierry Lefevre8, MD, FESC; Nicolaus Reifart9, MD, PhD, FESC for the EuroCTO Club
1. Klinikum Darmstadt, Darmstadt, Germany; 2. Royal Brompton Hospital & Imperial College, London, United Kingdom; 3. Ospedale Ferrarotto, Univ. of Catania, Catania, Italy; 4. Univ. of Leicester, Leicester, United Kingdom; 5. Ospedale di Mirano, Venice
In OAT patients with a recent myocardial infarction (MI) of 3-28 days with angiographically confirmed diagnosis of an occluded infarct-related artery, were randomised to medical treatment or to an interventional